SEMA3B switches axon-axon to axon-glia interactions required for unmyelinated axon envelopment and integrity https://www.nature.com/articles/s41467-025-61318-8
Discover the world at Altruu, The Discovery Engine
SEMA3B switches axon-axon to axon-glia interactions required for unmyelinated axon envelopment and integrity https://www.nature.com/articles/s41467-025-61318-8
Sustained Therapeutic Benefits Using Image-Guided Programming at Activation of Deep Brain Stimulation for Parkinson’s Disease
Congratulations to Drs. Michael S Okun, Adolfo Ramirez-Zamora, and Kelly Foote on the publication of “Sustained Therapeutic Benefits Using Image-Guided Programming at Activation of Deep Brain Stimulation for Parkinson’s Disease,” which appears in the June edition of Movement Disorder Clinical Practice. Abstract Background: The efficacy of deep brain stimulation (DBS) for Parkinson’s disease (PD) depends on optimizing stimulation…
https://neurology.ufl.edu/2025..../06/30/sustained-the
Metabolomic profiling of a dementia cohort in Egypt: a step towards a neuro-exposome model https://www.nature.com/articles/s44400-025-00021-3
Heterogeneous treatment effects of GLP‐1RAs and SGLT2is on risk of Alzheimer’s disease and related dementia in patients with type 2 diabetes: Insights from a real‐world target trial emulation
Congratulations to Dr. Steven DeKosky on the publication of “Heterogeneous treatment effects of GLP‐1RAs and SGLT2is on risk of Alzheimer’s disease and related dementia in patients with type 2 diabetes: Insights from a real‐world target trial emulation,” which appears in the May issue of Alzheimer’s and Dementia. Abstract INTRODUCTION This study assessed the heterogeneous treatment…
https://neurology.ufl.edu/2025..../06/27/heterogeneous
ADAT3-related neurodevelopmental disorder in 24 new patients with a high frequency of the p.Val144Met and a new founder variant https://www.nature.com/articles/s41598-025-06857-2